Clinical Trials Browser

Completed × cabozantinib × Plasma cell × Clear all

NCT01866293 2017-08-30

Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Phase 1/2 Completed

11 enrolled 12 charts

Multiple Myeloma, Recurrence

NCT01582295 2017-05-25

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Phase 1 Completed

Bone Diseases, Multiple Myeloma